Fig. 4From: The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathwayNKP608 inhibited Wnt/β-catenin signaling pathway in colorectal cancer cells. a Western blot revealed that NKP608 resulted in an inhibitory action of Wnt relative proteins and proteins relevant cell growth including β-catenin, Wnt-3a, E-Cadherin, Cyclin D1 and VEGF. b Quantitative expression levels of proteins are shown. Values are expressed as the mean ± SD (n = 3). *p < 0.05 versus NC groupBack to article page